Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | ATEC | Common Stock | Sale | -$1.62M | -100K | -100% | $16.15 | 0 | Jun 15, 2023 | Direct | F1 |
holding | ATEC | Common Stock | 11.1M | Jun 15, 2023 | See footnote | F2 |
Id | Content |
---|---|
F1 | This amendment corrects the original Form 4 which was filed in error on June 16, 2023. The Form 4 was intended to disclose that (i) 100,000 shares were sold on June 15, 2023 at (ii) at a price per share of $16.15 and (iii) zero shares were beneficially owned following the transaction. |
F2 | Paul Segal directly (through his position as manager of L-5 Healthcare Partners, LLC ("L-5")) may be deemed to control L-5 and to have shared voting and investment power with respect to the shares beneficially owned by L-5. As such, Mr. Segal may be deemed to have shared beneficial ownership of the shares beneficially owned by L-5. Mr. Segal, however, disclaims beneficial ownership of such shares, except to the extent of his indirect pecuniary interest therein. |